[go: up one dir, main page]

Morey et al., 2004 - Google Patents

Activity of microemulsion-based nanoparticles at the human bio-nano interface: concentration-dependent effects on thrombosis and hemolysis in whole blood

Morey et al., 2004

View PDF
Document ID
14660524780987737980
Author
Morey T
Varshney M
Flint J
Seubert C
Smith W
Bjoraker D
Shah D
Dennis D
Publication year
Publication venue
Journal of Nanoparticle Research

External Links

Snippet

Background: Although microemulsion-based nanoparticles (MEs) may be useful for drug delivery or scavenging, these benefits must be balanced against potential nanotoxicological effects in biological tissue (bio-nano interface). We investigated the actions of assembled …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender

Similar Documents

Publication Publication Date Title
Lo et al. Dextran and carrageenan evoke different inflammatory responses in rat with respect to composition of infiltrates and effect of indomethacin.
Rhee et al. Human neutrophil activation and increased adhesion by various resuscitation fluids
Morey et al. Activity of microemulsion-based nanoparticles at the human bio-nano interface: concentration-dependent effects on thrombosis and hemolysis in whole blood
AU2006308921B2 (en) Sodium chloride solution for drug reconstitution or dilution
Salmon et al. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction
Babaee et al. Salivary oxidant/antioxidant status and hematological parameters in patients with recurrent aphthous stomatitis
Pieters et al. Glycaemic control improves fibrin network characteristics in type 2 diabetes–a purified fibrinogen model
NZ553389A (en) Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use
Dirkmann et al. Anticoagulant Effect of Sugammadex
Hunt et al. A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER
Reinhart et al. Influence of contrast media (iopromide, ioxaglate, gadolinium‐DOTA) on blood viscosity, erythrocyte morphology and platelet function
Şen et al. Preventive effects of dexmedetomidine on the liver in a rat model of acid‐induced acute lung injury
Başkurt et al. Standard aggregating media to test the “aggregability” of rat red blood cells
Jain et al. Haematological changes in alcohol and substance use disorders-an overview
Wirtz et al. Washing or filtering of blood products does not improve outcome in a rat model of trauma and multiple transfusion
Tian et al. Effects of urban particulate matter on the quality of erythrocytes
JP2002040029A (en) Automated method for detecting, quantifying and monitoring exogenous hemoglobin in whole blood, plasma and serum
Sbrana et al. Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with Pirital virus (Arenaviridae): a rodent model of Lassa fever
EP1973929B1 (en) Anticoagulation of human blood ex vivo
Ferkau et al. Infection-associated platelet dysfunction of canine platelets detected in a flow chamber model
Udden Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2‐butoxyethanol: II. Resistance in red blood cells from humans with potential susceptibility
Dalgliesh et al. Babesia argentina: disseminated intravascular coagulation in acute infections in splenectomized calves
Kedziora‐Kornatowska Production of Superoxide and Nitric Oxide by Granulocytes in Non‐Insulin‐Dependent Diabetic Patients With and Without Diabetic Nephropathy
Udden et al. Decreased deform ability of erythrocytes and increased intracellular calcium in patients with chronic renal failure
Spector et al. Coagulation studies during experimental hemoglobinemia in humans